Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR)
| Autor: | Bernal-Mizrachi, Leon, Nooka, Ajay K., Heffner, Leonard, Cole, Craig E., Vij, Ravi, Ye, J Christine, Hofmeister, Craig C, Rushton, John *, Chen, Zhengjia *, Goyal, Subir *, Cinar, Munevver *, Lonial, Sagar, Kaufman, Jonathan L. |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:7311-7312 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|